Kelli L Boyd Selected Research

alpha Karyopherins

1/2019	Protection from Endotoxin Shock by Selective Targeting of Proinflammatory Signaling to the Nucleus Mediated by Importin Alpha 5.
1/2017	Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kelli L Boyd Research Topics

Disease

22	Inflammation (Inflammations) 11/2021 - 10/2007
20	Infections 01/2020 - 01/2005
9	Pneumonia (Pneumonitis) 11/2021 - 02/2009
9	Asthma (Bronchial Asthma) 11/2021 - 06/2013
9	Neoplasms (Cancer) 10/2021 - 01/2011
7	Virus Diseases (Viral Diseases) 05/2020 - 01/2005
7	Human Influenza (Influenza) 10/2019 - 02/2009
5	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2018
5	Obesity 11/2021 - 12/2012
5	Bacterial Pneumonia 01/2020 - 01/2005
5	Necrosis 01/2019 - 04/2009
4	Sepsis (Septicemia) 01/2019 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2011
3	Eosinophilia 01/2020 - 05/2014
3	Osteonecrosis (Kienbock's Disease) 01/2016 - 12/2012
3	Paramyxoviridae Infections (Parainfluenza) 01/2010 - 01/2005
2	Retinal Degeneration 11/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 10/2021 - 04/2012
2	Fatty Liver 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2020 - 01/2018
2	Wounds and Injuries (Trauma) 01/2018 - 09/2014
2	Respiratory Syncytial Virus Infections 01/2017 - 01/2016
2	Weight Loss (Weight Reduction) 01/2016 - 06/2012
2	Communicable Diseases (Infectious Diseases) 01/2015 - 05/2013
2	Bacterial Infections (Bacterial Infection) 09/2014 - 12/2011
2	Metabolic Diseases (Metabolic Disease) 12/2012 - 12/2012
2	Pneumococcal Pneumonia 11/2011 - 05/2011
2	Coinfection 03/2011 - 02/2009
1	Hyperglycemia 01/2022
1	Pregnancy Complications 01/2022
1	Bites and Stings (Sting) 10/2021
1	Cytopenia 01/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2007
10	CytokinesIBA 11/2018 - 02/2009
6	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2018
5	Retinaldehyde (Retinal)IBA 01/2022 - 01/2018
5	Interleukin-13IBA 01/2020 - 06/2013
4	LigandsIBA 10/2021 - 01/2016
4	Interleukin-33IBA 01/2020 - 01/2016
4	VaccinesIBA 10/2019 - 05/2013
4	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 03/2011
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2019
3	LipidsIBA 01/2020 - 01/2016
3	Peptides (Polypeptides)IBA 01/2019 - 10/2007
3	ChemokinesIBA 11/2018 - 06/2015
3	Pharmaceutical PreparationsIBA 01/2018 - 04/2012
3	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 12/2012
3	AntigensIBA 05/2013 - 03/2006
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 01/2015
2	Interleukin-10 (Interleukin 10)IBA 11/2021 - 01/2017
2	Histone Deacetylase InhibitorsIBA 11/2021 - 01/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 11/2021 - 11/2018
2	InterferonsIBA 10/2021 - 05/2014
2	Immune Checkpoint InhibitorsIBA 10/2021 - 05/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019
2	Karyopherins (Importin)IBA 01/2021 - 01/2019
2	Interleukin-4 (Interleukin 4)IBA 01/2020 - 09/2014
2	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2016
2	Thymic Stromal LymphopoietinIBA 01/2020 - 01/2016
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2018
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2019 - 04/2014
2	alpha KaryopherinsIBA 01/2019 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2015
2	Pattern Recognition ReceptorsIBA 01/2017 - 10/2015
2	Insulin (Novolin)FDA Link 01/2016 - 05/2014
2	GlucocorticoidsIBA 01/2016 - 07/2013
2	ProstaglandinsIBA 01/2016 - 11/2012
2	Neutralizing AntibodiesIBA 09/2015 - 03/2011
2	Monoclonal AntibodiesIBA 01/2015 - 08/2012
2	Interleukin-17 (Interleukin 17)IBA 09/2014 - 06/2013
2	OvalbuminIBA 09/2014 - 09/2013
2	EpitopesIBA 05/2013 - 08/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2011 - 02/2009
2	Hemagglutinins (Hemagglutinin)IBA 01/2011 - 01/2005
2	InflammasomesIBA 04/2010 - 03/2010
2	4- zido- 5- isobutyrylamino- 2,3- didehydro- 2,3,4,5- tetradeoxyglycerogalacto- 2- nonulopyranosic acidIBA 01/2009 - 01/2005
2	Neuraminidase (Sialidase)IBA 01/2009 - 01/2005
1	ImmunosorbentsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	belinostatIBA 11/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2021
1	AntibodiesIBA 10/2021
1	SolutionsIBA 01/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2021

Therapy/Procedure

13	Therapeutics 10/2021 - 01/2009
5	Drug Therapy (Chemotherapy) 11/2021 - 12/2012
3	Immunotherapy 05/2020 - 05/2011
2	Intravitreal Injections 01/2021 - 01/2018
2	Bariatric Surgery 12/2012 - 12/2012
2	Operative Surgical Procedures 12/2012 - 12/2012
1	Intravenous Administration 10/2021